Tarek A. Hammad - Publications, H-index & Citations

Tarek A. Hammad

takeda development center americas

35H指数

134论文数

5.1K被引数

收录论文 40

发表时间

Predictive Safety in the Era of Artificial Intelligence: Promises, Limits, and the Case for an Enterprise Lifecycle Evidence Ecosystem 人工智能时代的预测性安全：前景、局限及企业生命周期证据生态系统的必要性

Drug Safety

IF3.8

2026-08-28

OAAI

Tarek A. Hammad; Justine Rochon; Kate Gofman; Gianluca Trifirò; Andrew Bate

Augmenting Medical Judgment in Signal Confirmation: Design Considerations for an AI-Enabled Causality Assessment Framework 增强信号确认中的医疗判断：人工智能赋能的因果关系评估框架的设计考虑

Drug Safety

IF3.8

2026-07-15

OAAI

Tarek A. Hammad; Justine Rochon; Salman Afsar; Sue H. Lee; Dona M. Ely; Neda Hassanpour; Andrew Bate

Analytic Misjudgment of Drug Safety Evidence and Causality: From the Prosecutor’s Fallacy and Simpson’s Paradox to Artificial Intelligence 药品安全证据的分析误判与因果关系 -- 从检察官谬误、辛普森悖论到人工智能

Drug Safety

IF3.8

2026-06-12

OAAI

Tarek A. Hammad; Justine Rochon

9th ISoP Intelligent Automation Boston Seminar: From Innovation to Impact. Building Trustworthy AI in Pharmacovigilance 4–5 December 2025 | Cambridge, USA & Virtual 第九届ISoP智能自动化波士顿研讨会：从创新到影响。在药物警戒中构建可信赖的人工智能 2025年12月4-5日 | 美国剑桥，线上及线下

Drug Safety

IF3.8

2026-03-17

PREAI

Omar Aimer; Tarek A. Hammad; Jan Petracek; Mohamed Fouda; Angela Caro-Rojas; Andrew Bate; Veronique F. Kugener

Pharmacovigilance Due Diligence in Drug Development: A Practical Playbook for Risk Identification, Compliance Assessment, and Strategic Decision Making 药物警戒尽职调查在药物研发中的应用：一份用于风险识别、合规评估和战略决策制定的实用指南

Drug Safety

IF3.8

2025-12-16

OAAI

Ashraf Youssef; Tarek A. Hammad

Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting Practices 公开可用的临床试验安全数据：综述与标准化及改进报告实践的呼吁

Pharmaceutical Medicine

IF4.5

2025-12-16

OAAI

Barbara A. Hendrickson; Cynthia McShea; Tarek A. Hammad; Jaishri Meer; Wei Michelle Zhang; Edward Whalen; Susan Talbot; Ranjeeta Sinvhal; Maria Beatrice Panico; Li-An Lin; Dimitri Bennett

Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future Directions 东亚非干预性上市后研究的开展：监管挑战、机遇与未来方向

Drug Safety

IF3.8

2025-10-17

OAAI

Jami Peters; Ayad K. Ali; Maria Moitinho de Almeida; Keiko Asao; Tarek A. Hammad; Xintong He; Alexander Michel; Annalisa Rubino; Sono Sawada; Rachel E. Sobel; Stefan de Vogel

Reflections, operational lessons, and practical insights from a pharmacovigilance inspection: a case example of organizational strategies for medical safety readiness 反思、操作经验以及实践见解：来自一次药物警戒检查的案例，探讨医疗安全准备的组织策略

Therapeutic Advances in Drug Safety

IF3.4

2025-08-12

OAAI

Tarek A. Hammad; Sasan Sabrdaran; Hesham Aboshady; Raquel Rogers; Jean-Marie Heim; Kim Bullano; Tatiana Ishida

Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation Strategies 致畸风险影响缓解（TRIM）：明确标准的发展，以促进关于致畸风险缓解策略的决策

Drug Safety

IF3.8

2025-08-05

OAAI

Celeste L. Y. Ewig; Yanning Wang; Nicole E. Smolinski; Gita A. Toyserkani; Cynthia LaCivita; Leila Lackey; Sara Eggers; Leyla Sahin; Reem S. Abu-Rustum; Brian T. Bateman; Anick Berard; Christina D. Chambers; Beth Choby; Elizabeth A. Conover; Michael F. Greene; Sonia Hernández-Díaz; Denise J. Jamieson; Sarah G. Običan; Janine E. Polifka; Kay Roussos-Ross; Jeanne S. Sheffield; Sharon Voyer Lavigne; Ellen M. Zimmermann; Susan B. Laffan; Anthony M. DeLise; Alicia W. Gilsenan; Tarek A. Hammad; Christian Hampp; Janet R. Hardy; Caitlin A. Knox; Kristine Shields; Meredith Y. Smith; Rachel E. Sobel; Melissa S. Tassinari; Judith C. Maro; Sonja A. Rasmussen; Almut G. Winterstein

Exploring the complexities of disproportionality analysis in pharmacovigilance: reflections on the READUS-PV guideline and a call to action 探索药物警戒中不成比例性分析的复杂性：关于READUS-PV指南的反思与行动呼吁

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-04-09

OAAI

Hammad, Tarek A.; Naylor, Melissa; Ely, Dona M.; Davies, Simon

Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance

DRUG SAFETY

IF3.8

2025-04-01

OAAI

Crisafulli, Salvatore; Bate, Andrew; Brown, Jeffrey Stuart; Candore, Gianmario; Chandler, Rebecca E.; Hammad, Tarek A.; Lane, Samantha; Maro, Judith Christina; Noren, G. Niklas; Pariente, Antoine; Russom, Mulugeta; Salas, Maribel; Segec, Andrej; Shakir, Saad; Spini, Andrea; Toh, Sengwee; Tuccori, Marco; van Puijenbroek, Eugene; Trifiro, Gianluca

Navigating Diverging Perspectives: Reasoning, Evidence, and Decision-Making in Drug Safety

DRUG SAFETY

IF3.8

2025-03-01

OAAI

Hammad, Tarek A.; Davies, Simon

Advances in Drug Safety: Highlights from the 23rd Annual Meeting of the International Society of Pharmacovigilance

DRUG SAFETY

IF3.8

2024-12-18

PREAI

Aimer, Omar; Salas, Maribel; Hammad, Tarek A.; Mouchantaf, Rania; Ilic, Katarina; Gossell-Williams, Maxine; Mehta, Ushma; Platt, Robert W.; Carleton, Bruce

Strategic Partnerships in Pharmacovigilance: Business, Legal, and Regulatory Domains

CLINICAL THERAPEUTICS

IF3.6

2024-05-01

PREAI

Youssef, Ashraf; Blanchard, Nancy L.; Hammad, Tarek A.

Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial

CARDIOVASCULAR DIABETOLOGY

IF10.6

2019-06-24

OAAI

Sheikh, Omar; Vande Hei, Anthony G.; Battisha, Ayman; Hammad, Tarek; Son Pham; Chilton, Robert

INCORPORATING PSYCHOLOGICAL CONSTRUCTS INTO PATIENT PREFERENCE STUDIES: WHICH YOU SHOULD CONSIDER INCLUDING IN YOUR NEXT STUDY?

VALUE IN HEALTH

IF6

2018-10-01

OAAI

Monzani, D.; Russo, S.; Kihlbom, U.; Jongerius, C.; Faccio, F.; Pizzoli, S. F.; Marton, G.; Vergani, L.; Pinto, C. A.; Harding, S.; Janssens, R.; Huys, I; Kubler, J.; Simons, G.; Falahee, M.; Hermann, R.; Hammad, T.; Pravettoni, G.

COMPENDIUM OF METHODS FOR MEASURING PATIENT PREFERENCES IN MEDICAL TREATMENT

VALUE IN HEALTH

IF6

2017-10-01

OAAI

Soekhai, V; Whichello, C.; Levitan, B.; Veldwijk, J.; Hammad, T.; Kihlbom, U.; van Overbeeke, E.; Russo, S.; Mohamed, A.; Hermann, R.; Huys, I; Patadia, V; Juhaeri, J.; de Bekker-Grob, E.

The Contemporary Role of Stents and Angioplasty for the Treatment of Infrapopliteal Disease in Critical Limb Ischemia

CURRENT CARDIOLOGY REPORTS

IF3.3

2017-05-15

PREAI

Hammad, Tarek A.; Prasad, Anand

Prognostic value of an increase in post-exercise ankle-brachial index

VASCULAR MEDICINE

IF3.3

2016-12-01

OAAI

Hammad, Tarek A.; Hiatt, William R.; Gornik, Heather L.; Shishehbor, Mehdi H.